The production of autoantibodies to self antigens is dependent on the failure of immune tolerance. Cancer cells express antigens which elicit a spontaneous immune response in cancer patients. The repertoire of autoantibodies found in cancer patients partly covers that of patients with autoimmune diseases. Biological activities of autoantibodies to self antigens may induce paraneoplastic syndromes which reflect the attempt of cancer patients to counteract tumor growth. Autoantibodies with similar specificities may have different effects in cancer and autoimmune disease patients due to different immunological microenvironments. Tregs dysfunction has been observed in patients with paraneoplastic syndromes and/or with autoimmune diseases, while the increase of Tregs has been associated with poor cancer patients prognosis. Novel therapies have employed antibodies against Tregs immune-checkpoint receptors with the aim to boost immune response in cancer patients. The presence of autoantibodies to tumors antigens has also been investigated as a marker for cancer detection and cancer patients prognosis. This report reviews the current knowledge on the analysis and meaning of autoantibodies to self antigens detected in cancer and autoimmune disease patients.

Benvenuto, M., Mattera, R., Masuelli, L., Tresoldi, I., Giganti, M.G., Frajese, G., et al. (2017). The crossroads between cancer immunity and autoimmunity: antibodies to self antigens. FRONTIERS IN BIOSCIENCE, 22, 1289-1329 [10.2741/4545].

The crossroads between cancer immunity and autoimmunity: antibodies to self antigens

GIGANTI, MARIA GABRIELLA;MANZARI, VITTORIO;MODESTI, ANDREA;BEI, ROBERTO
2017-03-01

Abstract

The production of autoantibodies to self antigens is dependent on the failure of immune tolerance. Cancer cells express antigens which elicit a spontaneous immune response in cancer patients. The repertoire of autoantibodies found in cancer patients partly covers that of patients with autoimmune diseases. Biological activities of autoantibodies to self antigens may induce paraneoplastic syndromes which reflect the attempt of cancer patients to counteract tumor growth. Autoantibodies with similar specificities may have different effects in cancer and autoimmune disease patients due to different immunological microenvironments. Tregs dysfunction has been observed in patients with paraneoplastic syndromes and/or with autoimmune diseases, while the increase of Tregs has been associated with poor cancer patients prognosis. Novel therapies have employed antibodies against Tregs immune-checkpoint receptors with the aim to boost immune response in cancer patients. The presence of autoantibodies to tumors antigens has also been investigated as a marker for cancer detection and cancer patients prognosis. This report reviews the current knowledge on the analysis and meaning of autoantibodies to self antigens detected in cancer and autoimmune disease patients.
Pubblicato
Rilevanza internazionale
Articolo
Esperti anonimi
Settore MED/04 - Patologia Generale
English
Con Impact Factor ISI
Benvenuto, M., Mattera, R., Masuelli, L., Tresoldi, I., Giganti, M.G., Frajese, G., et al. (2017). The crossroads between cancer immunity and autoimmunity: antibodies to self antigens. FRONTIERS IN BIOSCIENCE, 22, 1289-1329 [10.2741/4545].
Benvenuto, M; Mattera, R; Masuelli, L; Tresoldi, I; Giganti, Mg; Frajese, G; Manzari, V; Modesti, A; Bei, R
Articolo su rivista
File in questo prodotto:
File Dimensione Formato  
Benvenuto et al FBS Landmark.pdf

non disponibili

Tipologia: Versione Editoriale (PDF)
Licenza: Non specificato
Dimensione 767.17 kB
Formato Adobe PDF
767.17 kB Adobe PDF   Visualizza/Apri   Richiedi una copia

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: http://hdl.handle.net/2108/174740
Citazioni
  • ???jsp.display-item.citation.pmc??? 6
  • Scopus 12
  • ???jsp.display-item.citation.isi??? 12
social impact